H-H Parving Selected Research

Insulin (Novolin)

1/2017	Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.
4/2012	Insulin analogues and severe hypoglycaemia in type 1 diabetes.
5/2007	Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
9/2002	Total plasma homocysteine is associated with hypertension in Type I diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H-H Parving Research Topics

Disease

21	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 01/2002
18	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2005
16	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 11/2004
10	Albuminuria 02/2016 - 01/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2005
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 02/2005
3	Inflammation (Inflammations) 09/2012 - 05/2007
3	Hypertension (High Blood Pressure) 08/2010 - 09/2002
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 06/2011
2	Proteinuria 06/2008 - 10/2005
2	Acute Coronary Syndrome 12/2007 - 01/2005
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2005 - 10/2005
2	Diabetes Complications 08/2004 - 11/2003
1	Chronic Renal Insufficiency 01/2016
1	Anemia 01/2016
1	Stillbirth 06/2011
1	Spontaneous Abortion (Miscarriage) 06/2011
1	Vascular Calcification 11/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2007
1	Body Weight (Weight, Body) 05/2007
1	Insulin Resistance 05/2007
1	Essential Hypertension 01/2006
1	Heart Failure 01/2005
1	Stroke (Strokes) 01/2005
1	Myocardial Infarction 01/2005

Drug/Important Bio-Agent (IBA)

9	CreatinineIBA 01/2016 - 01/2002
8	AlbuminsIBA 01/2016 - 10/2005
7	Antihypertensive Agents (Antihypertensives)IBA 08/2012 - 11/2005
6	Losartan (Cozaar)FDA LinkGeneric 02/2014 - 11/2004
4	Insulin (Novolin)FDA Link 01/2017 - 09/2002
4	Angiotensin Receptor AntagonistsIBA 02/2016 - 01/2006
4	aliskiren FDA Link 02/2016 - 06/2008
4	Angiotensin IIIBA 02/2014 - 02/2005
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2003
3	CholesterolIBA 08/2012 - 01/2002
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2006 - 01/2005
3	pro-brain natriuretic peptide (1-76)IBA 10/2006 - 01/2005
3	AldosteroneIBA 08/2006 - 11/2004
2	LectinsIBA 01/2020 - 01/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2016 - 01/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2012 - 03/2012
2	Spironolactone (Aldactone)FDA LinkGeneric 08/2012 - 08/2006
2	Lisinopril (Prinivil)FDA LinkGeneric 10/2010 - 01/2009
2	Metformin (Glucophage)FDA LinkGeneric 10/2009 - 05/2007
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 06/2006 - 01/2006
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2021
1	Advanced Glycation End ProductsIBA 01/2021
1	Irbesartan FDA LinkGeneric 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	3-deoxyglucosoneIBA 01/2021
1	Glyoxal (Ethanedial)IBA 01/2021
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2017
1	Darbepoetin alfa (Aranesp)FDA Link 01/2016
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2015
1	HydrogenIBA 05/2013
1	CytokinesIBA 09/2012
1	HMGB1 Protein (HMG1)IBA 09/2012
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 04/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012
1	candesartanIBA 06/2011
1	PotassiumIBA 01/2011
1	Lipocalin-2IBA 10/2010
1	erucylphosphocholineIBA 10/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2009
1	LipidsIBA 10/2009
1	CalciumIBA 01/2009
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2009
1	paricalcitol (Zemplar)FDA Link 01/2009
1	Parathyroid Hormone (Parathormone)IBA 01/2009
1	Furosemide (Lasix)FDA LinkGeneric 01/2009
1	Peptides (Polypeptides)IBA 11/2008
1	OsteoprotegerinIBA 11/2008
1	alanylalanine (Ala-Ala)IBA 07/2008
1	PPAR gammaIBA 07/2008
1	ReninIBA 06/2008
1	Protein Kinase C betaIBA 04/2008
1	Protein Kinase CIBA 04/2008
1	Messenger RNA (mRNA)IBA 04/2008
1	Protein Isoforms (Isoforms)IBA 04/2008
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 12/2007
1	repaglinide (Prandin)FDA Link 05/2007
1	SecretagoguesIBA 05/2007
1	Pharmaceutical PreparationsIBA 05/2007
1	C-PeptideIBA 05/2007
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2006
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2006
1	AdiponectinIBA 09/2005
1	Serum AlbuminIBA 02/2005
1	Natriuretic PeptidesIBA 01/2005
1	polyolIBA 08/2004
1	Aldehyde Reductase (Aldose Reductase)IBA 08/2004
1	HomocysteineIBA 09/2002

Therapy/Procedure

4	Therapeutics 02/2016 - 04/2006
1	Surgical Amputation (Amputations) 01/2005